Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 5 | 2024 | 516 | 0.910 |
Why?
|
| Proteomics | 1 | 2021 | 177 | 0.650 |
Why?
|
| STAT3 Transcription Factor | 2 | 2015 | 92 | 0.500 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 8 | 0.490 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2015 | 7 | 0.490 |
Why?
|
| Naphthoquinones | 1 | 2015 | 11 | 0.490 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 447 | 0.330 |
Why?
|
| Signal Transduction | 5 | 2024 | 1379 | 0.270 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 2 | 2024 | 10 | 0.260 |
Why?
|
| Antigen Presentation | 1 | 2024 | 78 | 0.220 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 375 | 0.210 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2022 | 6 | 0.200 |
Why?
|
| Sirtuins | 1 | 2021 | 17 | 0.190 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 60 | 0.180 |
Why?
|
| NADPH Oxidase 4 | 1 | 2020 | 8 | 0.180 |
Why?
|
| Precision Medicine | 1 | 2021 | 68 | 0.170 |
Why?
|
| Sirtuin 1 | 1 | 2020 | 40 | 0.170 |
Why?
|
| Energy Metabolism | 1 | 2021 | 186 | 0.170 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 133 | 0.160 |
Why?
|
| Tumor Burden | 2 | 2021 | 108 | 0.160 |
Why?
|
| Cachexia | 1 | 2020 | 51 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 310 | 0.160 |
Why?
|
| Magnesium Hydroxide | 1 | 2016 | 1 | 0.130 |
Why?
|
| Aluminum Hydroxide | 1 | 2016 | 3 | 0.130 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 1268 | 0.130 |
Why?
|
| Humans | 8 | 2024 | 27121 | 0.130 |
Why?
|
| Mice | 5 | 2024 | 4474 | 0.120 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2015 | 2 | 0.120 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 33 | 0.120 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 53 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2016 | 110 | 0.120 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 180 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 73 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 110 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 138 | 0.110 |
Why?
|
| Animals | 6 | 2024 | 10085 | 0.110 |
Why?
|
| Cell Survival | 1 | 2015 | 395 | 0.110 |
Why?
|
| Cell Movement | 1 | 2015 | 353 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2024 | 247 | 0.100 |
Why?
|
| Interleukin-11 | 1 | 2012 | 6 | 0.100 |
Why?
|
| Trophoblasts | 1 | 2012 | 13 | 0.100 |
Why?
|
| Transcription Factor AP-1 | 1 | 2012 | 26 | 0.100 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 31 | 0.100 |
Why?
|
| Cell Proliferation | 1 | 2015 | 774 | 0.100 |
Why?
|
| Mucins | 1 | 2012 | 22 | 0.100 |
Why?
|
| Neoplasms | 1 | 2020 | 766 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 658 | 0.090 |
Why?
|
| Mucin-1 | 2 | 2024 | 36 | 0.080 |
Why?
|
| Disease Progression | 2 | 2021 | 458 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 1496 | 0.070 |
Why?
|
| Female | 3 | 2021 | 14636 | 0.060 |
Why?
|
| Quinaldines | 1 | 2024 | 5 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2024 | 17 | 0.060 |
Why?
|
| Biphenyl Compounds | 1 | 2024 | 22 | 0.060 |
Why?
|
| Melanoma, Experimental | 1 | 2024 | 29 | 0.060 |
Why?
|
| Polyamines | 1 | 2024 | 12 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2024 | 36 | 0.060 |
Why?
|
| Middle Aged | 1 | 2015 | 6900 | 0.060 |
Why?
|
| Adult | 1 | 2015 | 7492 | 0.050 |
Why?
|
| Pyrimidine Nucleotides | 1 | 2022 | 4 | 0.050 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2022 | 15 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2022 | 121 | 0.050 |
Why?
|
| Aspartate Aminotransferase, Cytoplasmic | 1 | 2021 | 6 | 0.050 |
Why?
|
| Enzyme Activators | 1 | 2021 | 9 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2021 | 59 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 49 | 0.050 |
Why?
|
| Deoxycytidine | 1 | 2021 | 63 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2021 | 265 | 0.050 |
Why?
|
| Wasting Syndrome | 1 | 2020 | 7 | 0.040 |
Why?
|
| Protein Stability | 1 | 2020 | 42 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 34 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2020 | 31 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 251 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2020 | 50 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 175 | 0.040 |
Why?
|
| Metabolome | 1 | 2020 | 66 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2020 | 187 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 355 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2020 | 180 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 280 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2021 | 794 | 0.040 |
Why?
|
| Cell Line | 1 | 2020 | 682 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 445 | 0.040 |
Why?
|
| Mutation | 1 | 2021 | 818 | 0.040 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2016 | 8 | 0.030 |
Why?
|
| Anions | 1 | 2016 | 15 | 0.030 |
Why?
|
| Drug Liberation | 1 | 2016 | 24 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 39 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2016 | 50 | 0.030 |
Why?
|
| Particle Size | 1 | 2016 | 96 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 622 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2016 | 206 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 264 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1405 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 546 | 0.030 |
Why?
|
| Male | 2 | 2021 | 13022 | 0.030 |
Why?
|
| Rats | 1 | 2016 | 1554 | 0.020 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2012 | 1 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 13 | 0.020 |
Why?
|
| Embryo Implantation | 1 | 2012 | 5 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 17 | 0.020 |
Why?
|
| Integrins | 1 | 2012 | 27 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 49 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 64 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2012 | 116 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2012 | 135 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 121 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2012 | 143 | 0.020 |
Why?
|